Literature DB >> 3335869

The effectiveness of cervical screening: a population-based case-control study.

Y van der Graaf1, G A Zielhuis, P G Peer, P G Vooijs.   

Abstract

The cervical smear histories of 36 women with invasive cervical cancer were compared to those of 120 age-matched controls, drawn from local registrar's offices. Of the cases 47% were screened at least once, while for the controls this figure was 68%. The relative risk of getting invasive cervical cancer for women screened at least once compared to women who were never screened was 0.32. The most important confounding factor was age at first intercourse. Contrary to other studies however, it was found that women who were younger when having first intercourse were screened more often. After correcting the relative risk of screened vs unscreened for age at first intercourse, the relative risk became 0.22. When the length of the interval since the last smear was considered, the relative risk was 0.18 when the smear was made between 2 and 5 years earlier and 0.30 when this smear was made more than 5 years earlier. These results support the assumption that screening is effective in the prevention of invasive cancer of the uterine cervix. Even a screening interval of more than 5 years provides considerable protection.

Entities:  

Mesh:

Year:  1988        PMID: 3335869     DOI: 10.1016/0895-4356(88)90005-4

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  16 in total

Review 1.  Report of a National Workshop on Screening for Cancer of the Cervix.

Authors:  A B Miller; G Anderson; J Brisson; J Laidlaw; N Le Pitre; P Malcolmson; P Mirwaldt; G Stuart; W Sullivan
Journal:  CMAJ       Date:  1991-11-15       Impact factor: 8.262

2.  Pap tests of rural black women.

Authors:  J A Sawyer; J Earp; R H Fletcher; F F Daye; T M Wynn
Journal:  J Gen Intern Med       Date:  1990 Mar-Apr       Impact factor: 5.128

3.  Application of the Carolina Framework for Cervical Cancer Prevention.

Authors:  Jennifer L Moss; Schatzi H McCarthy; Melissa B Gilkey; Noel T Brewer
Journal:  Gynecol Oncol       Date:  2013-12-10       Impact factor: 5.482

4.  Primary screening for high risk HPV by home obtained cervicovaginal lavage is an alternative screening tool for unscreened women.

Authors:  M A E Nobbenhuis; T J M Helmerhorst; A J C van den Brule; L Rozendaal; L H Jaspars; F J Voorhorst; R H M Verheijen; C J L M Meijer
Journal:  J Clin Pathol       Date:  2002-06       Impact factor: 3.411

5.  Prostate-specific antigen screening and mortality from prostate cancer.

Authors:  Stephen W Marcella; George G Rhoads; Jeffrey L Carson; Frances Merlino; Homer Wilcox
Journal:  J Gen Intern Med       Date:  2008-01-03       Impact factor: 5.128

6.  The effect of self-sampled HPV testing on participation to cervical cancer screening in Italy: a randomised controlled trial (ISRCTN96071600).

Authors:  P Giorgi Rossi; L M Marsili; L Camilloni; A Iossa; A Lattanzi; C Sani; C Di Pierro; G Grazzini; C Angeloni; P Capparucci; A Pellegrini; M L Schiboni; A Sperati; M Confortini; C Bellanova; A D'Addetta; E Mania; C B Visioli; E Sereno; F Carozzi
Journal:  Br J Cancer       Date:  2010-12-21       Impact factor: 7.640

7.  Exposure Definition in Case-Control Studies of Cervical Cancer Screening: A Systematic Literature Review.

Authors:  Alejandra Castanon; Aruna Kamineni; K Miriam Elfström; Anita W W Lim; Peter Sasieni
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2021-09-14       Impact factor: 4.254

8.  Population-based case-control study on cancer screening.

Authors:  T Sobue; T Suzuki; I Fujimoto; N Yokoi; T Naruke
Journal:  Environ Health Perspect       Date:  1990-07       Impact factor: 9.031

9.  Cervical cytology reported as negative and risk of adenocarcinoma of the cervix: no strong evidence of benefit.

Authors:  H Mitchell; G Medley; I Gordon; G Giles
Journal:  Br J Cancer       Date:  1995-04       Impact factor: 7.640

10.  Preventive Pap-smears: balancing costs, risks and benefits.

Authors:  M van Ballegooijen; J D Habbema; G J van Oortmarssen; M A Koopmanschap; J T Lubbe; H M van Agt
Journal:  Br J Cancer       Date:  1992-06       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.